Product Information

DILTIAZEM 24H ER(CD) 360 MG CP is a generic product labeled by Actavis Pharma, Inc., priced at $0.3532 per EA under NDC 00228291809. Its NADAC has been published 656 times since Jan 29, 2014.

FDA first approved this application on Dec 7, 2012. Its Orange Book therapeutic-equivalence code is AB3 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

DILTIAZEM 24H ER(CD) 360 MG CP

Diltiazem Hydrochloride
$0.3532per EA

Strength

360 mg/1

NDC

00228291809

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

DILTIAZEM HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA202463

FDA Approved

12/7/2012

TE Code

AB3

On Market Since

11/25/2013

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A4 Inhibitors

Price Statistics

The NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has been published 656 times since Jan 29, 2014, and over the history we have for it it has declined 95.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3532 per EA
All-time high$8.5758 (Oct 15, 2014)
All-time low$0.1898 (Jul 17, 2024)
52-week high$0.3601
52-week low$0.3270
Median price$3.2854
Average price$3.5910
Largest weekly change+82.3% (Oct 21, 2020)
Weeks tracked656
Tracking sinceJan 29, 2014

Price History

1W

-1.2%

1M

+0.8%

3M

+0.1%

6M

+0.1%

1Y

+6.9%

3Y

+21.4%

5Y

-85.5%

All

-95.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of DILTIAZEM 24H ER(CD) 360 MG CP?

The current National Average Drug Acquisition Cost (NADAC) for DILTIAZEM 24H ER(CD) 360 MG CP, manufactured by Actavis Pharma, Inc., is $0.3532 per EA (NDC 00228291809), effective Aug 19, 2026.

How has the price of DILTIAZEM 24H ER(CD) 360 MG CP changed over time?

Over the history we have for it, the NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has declined 95.7%. It has been tracked across 656 weekly CMS publications since Jan 29, 2014.

What are the highest and lowest recorded NADAC prices for DILTIAZEM 24H ER(CD) 360 MG CP?

Since Jan 29, 2014, the NADAC for DILTIAZEM 24H ER(CD) 360 MG CP has ranged from a low of $0.1898 (Jul 17, 2024) to a high of $8.5758 (Oct 15, 2014), with a median of $3.2854 per EA.

Are there cheaper alternatives to DILTIAZEM 24H ER(CD) 360 MG CP?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DILTIAZEM 24HR ER 360 MG CAP, is $0.3299 per EA — about 7% below DILTIAZEM 24H ER(CD) 360 MG CP.

Who manufactures DILTIAZEM 24H ER(CD) 360 MG CP?

DILTIAZEM 24H ER(CD) 360 MG CP (NDC 00228291809) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.